+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dried Blood Spot Collection Cards Market by Application, Product Type, End User, Distribution Channel, Sample Type - Global Forecast to 2030- Product Image
Dried Blood Spot Collection Cards Market by Application, Product Type, End User, Distribution Channel, Sample Type - Global Forecast to 2030- Product Image
Sale

Dried Blood Spot Collection Cards Market by Application, Product Type, End User, Distribution Channel, Sample Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337148
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Dried Blood Spot Collection Cards Market grew from USD 384.31 million in 2024 to USD 406.04 million in 2025. It is expected to continue growing at a CAGR of 5.60%, reaching USD 533.13 million by 2030.

Emergence of Dried Blood Spot Cards as a Game-Changer in Biomedical Sampling

The integration of dried blood spot collection cards into clinical and research settings has transformed the approach to sample acquisition and processing. By enabling minimally invasive sampling and reducing logistical burdens, these cards have become indispensable tools for healthcare providers, laboratories, and field researchers alike.

As adoption expands, the technology’s ability to streamline sample collection without compromising analytical accuracy has driven widespread acceptance. Its compatibility with diverse analytical platforms, from immunoassays to mass spectrometry, underscores its versatility in supporting diagnostic and surveillance programs globally.

Today’s decision-makers are recognizing the dual value of operational efficiency and patient-centric sampling. The introduction of custom card chemistries and standardized protocols has addressed earlier concerns around sample integrity, positioning dried blood spot cards as a scalable solution for emerging healthcare challenges and research frontiers.

Pioneering Innovations and Operational Transitions Redefining Sample Collection

Recent years have witnessed pivotal shifts reshaping how dried blood spot cards are developed, distributed, and utilized. Advancements in card matrix design now offer enhanced absorption and elution efficiencies, directly impacting analytical sensitivity and reproducibility.

Concurrently, the convergence of digital health platforms and remote sampling has elevated the role of home-based collection, enabling longitudinal studies and decentralized clinical trials. This shift toward patient-centric sampling is bolstered by integrated barcoding and tracking systems, ensuring chain-of-custody integrity from collection to analysis.

Sustainability considerations have also influenced material selection and manufacturing processes, with suppliers exploring eco-friendly substrates and solvent-free coating techniques. These innovations are not only reducing environmental footprints but also aligning product portfolios with evolving regulatory expectations and corporate responsibility goals.

Evaluating the Economic Repercussions of New Tariff Structures on Supply Dynamics

The implementation of additional tariffs on laboratory supplies in 2025 has imposed new cost pressures across the dried blood spot supply chain. Importers are navigating higher duties on raw card substrates, reagents used in coating processes, and ancillary packaging materials sourced from overseas suppliers.

These increased expenses are prompting manufacturers to reassess procurement strategies and explore regional sourcing alternatives. Some producers have accelerated partnerships with domestic substrate mills to mitigate exposure to cross-border rate fluctuations, while others are adopting lean inventory models to balance working capital and supply continuity.

Despite these headwinds, strategic price negotiations and value-based offerings are enabling key players to maintain competitive positioning. By absorbing partial duty impacts and highlighting total cost of ownership benefits, vendors are preserving adoption momentum even as budgetary constraints tighten in research and healthcare institutions.

Differentiated Market Pathways Uncovered Through Multi-Dimensional Segmentation

Insights into market segmentation reveal differentiated growth pathways and usage patterns across applications, product formats, end users, distribution models, and sample varieties. In clinical diagnostics, demand is surging for newborn screening assays targeting congenital hypothyroidism and phenylketonuria, while therapeutic drug monitoring tests for antiepileptics and immunosuppressants are driving uptake among chronic care providers.

Filter paper cards continue to represent the foundational product type, favored for their established performance and regulatory acceptance, whereas polymer coated cards are gaining traction in specialized workflows that require enhanced analyte stability and recovery. Diagnostic laboratories remain the predominant end users, though hospitals and home care settings are rapidly ramping up in-house sampling capabilities, supported by research institutes exploring novel epidemiological applications.

Distribution channels are evolving in step with end-user preferences. Direct sales engagements facilitate customized offerings and technical support, while indirect channels-encompassing distributor networks and e-commerce platforms such as corporate websites and online marketplaces-address volume procurement and global reach. Across sample types, whole blood spots maintain majority share, but serum and plasma spot formats are emerging as niche solutions for specific biomarker analyses.

Diverse Regional Growth Drivers and Regulatory Environments Across Key Markets

Regional dynamics underscore distinct adoption curves and regulatory frameworks shaping market trajectories. In the Americas, robust newborn screening programs and expansive pharmacokinetic research initiatives have created sustained demand for established blood spot platforms, while domestic manufacturing investments are reducing lead times and import dependencies.

The Europe, Middle East & Africa region is characterized by heterogeneous regulatory landscapes and burgeoning disease surveillance programs. Collaborative public health efforts in certain Middle Eastern countries are leveraging dried blood spots for outbreak monitoring, and European certification standards are fostering cross-border harmonization of sampling and assay protocols.

Asia-Pacific presents the highest growth potential, driven by expanding clinical trial activities, rising awareness of decentralized testing, and government-backed initiatives to strengthen rural healthcare infrastructure. Manufacturers are establishing regional distribution hubs and localized training programs to capitalize on evolving regulatory clearances and to address unique logistical challenges in remote territories.

Competitive Alignment Through Partnerships, Innovations, and Portfolio Expansion

Market leadership is influenced by a mix of established instrument vendors with integrated assay solutions and specialized card manufacturers focused on substrate innovation. Certain global players have fortified their positions through acquisitions that expand card portfolios and analytical service offerings, while niche innovators are differentiating via proprietary surface chemistries that optimize recovery for low-abundance analytes.

Strategic partnerships with diagnostic laboratories and contract research organizations have enabled rapid deployment of validated workflows, positioning these companies as preferred suppliers for clinical trials and large-scale surveillance studies. Regional suppliers are also gaining traction by providing tailored compliance support and agile manufacturing capabilities to meet localized standards and demand fluctuations.

The competitive landscape is further nuanced by collaborations between card producers and instrument developers to deliver end-to-end sampling and analysis platforms. These alliances aim to reduce adoption barriers by simplifying workflow integration and offering bundled service agreements that align with enterprise procurement strategies.

Strategic Initiatives to Fortify Market Resilience and Drive Differentiation

Industry leaders should prioritize diversification of supply chains by establishing multi-sourcing agreements and nearshoring critical substrate manufacturing to reduce exposure to tariff volatility. Investing in R&D collaborations focused on advanced coating technologies will further enhance card performance for emerging biomarker applications.

Enhancing digital integration across sampling workflows-through IoT-enabled tracking and automated data capture-will address rising demands for remote monitoring and real-time analytics. Leaders can also explore value-based service models that bundle sampling kits, data management tools, and analytical support, reinforcing customer loyalty and capturing recurring revenue streams.

Engaging proactively with regulatory bodies to streamline validation pathways and to contribute to updated guidelines on dried blood spot sampling will safeguard market access and elevate product credibility. Finally, forging alliances with academic institutions and public health agencies can extend addressable markets through joint studies and pilot programs in underpenetrated regions.

Robust Qualitative and Quantitative Analyses Anchored in Multi-Source Validation

The research methodology underpinning this analysis comprised a rigorous blend of primary and secondary data collection. Interviews with industry executives, laboratory directors, and procurement specialists provided firsthand insights into adoption motivations, procurement challenges, and pricing strategies across major markets.

Secondary sources encompassed peer-reviewed journals, regulatory filings, patent databases, and corporate disclosures, ensuring a comprehensive view of technological advancements and competitive activities. Regional trade data and tariff schedules were meticulously reviewed to quantify the operational impacts of duty changes and to identify potential sourcing alternatives.

Data triangulation and cross-validation techniques were applied throughout to bolster analytical rigor and to minimize bias. Market participants were surveyed to corroborate trends, and forecast assumptions were stress-tested against historical performance and scenario analyses, delivering robust strategic intelligence for decision-makers.

Synthesizing Insights to Inform Strategic Positioning and Future Pathways

This comprehensive examination of dried blood spot collection cards highlights a market at the intersection of technological innovation and evolving healthcare imperatives. While tariff pressures introduce pricing complexities, they also spur strategic realignments that enhance supply chain resilience and foster domestic manufacturing initiatives.

Segmentation insights reveal targeted opportunities across applications, product types, end users, distribution channels, and sample formats, enabling stakeholders to tailor offerings and to deploy region-specific go-to-market strategies. Regional analyses underscore the importance of localized regulatory expertise and partnership models to navigate diverse healthcare ecosystems effectively.

Competitive profiling and best-practice benchmarking underscore the value of collaborative R&D, integrated workflow solutions, and digital enablement to sustain differentiation. By leveraging these insights, organizations can position themselves to capitalize on emerging demands for decentralized testing, longitudinal monitoring, and advanced biomarker discovery.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Clinical Diagnostics
    • Disease Surveillance
    • Forensic Toxicology
    • Newborn Screening
      • Congenital Hypothyroidism
      • Phenylketonuria
    • Pharmacokinetics
    • Therapeutic Drug Monitoring
      • Antiepileptics
      • Immunosuppressants
  • Product Type
    • Filter Paper Cards
    • Polymer Coated Cards
  • End User
    • Diagnostic Laboratories
    • Home Care Settings
    • Hospitals
    • Research Institutes
  • Distribution Channel
    • Direct Sales
    • Indirect Sales
      • Distributors
      • E Commerce
        • Company Websites
        • Online Marketplaces
  • Sample Type
    • Plasma Spots
    • Serum Spots
    • Whole Blood Spots
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Danaher Corporation
  • PerkinElmer, Inc.
  • Ahlstrom-Munksjö Oyj
  • Bio-Rad Laboratories, Inc.
  • Roche Holding AG
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dried Blood Spot Collection Cards Market, by Application
8.1. Introduction
8.2. Clinical Diagnostics
8.3. Disease Surveillance
8.4. Forensic Toxicology
8.5. Newborn Screening
8.5.1. Congenital Hypothyroidism
8.5.2. Phenylketonuria
8.6. Pharmacokinetics
8.7. Therapeutic Drug Monitoring
8.7.1. Antiepileptics
8.7.2. Immunosuppressants
9. Dried Blood Spot Collection Cards Market, by Product Type
9.1. Introduction
9.2. Filter Paper Cards
9.3. Polymer Coated Cards
10. Dried Blood Spot Collection Cards Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.3. Home Care Settings
10.4. Hospitals
10.5. Research Institutes
11. Dried Blood Spot Collection Cards Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Indirect Sales
11.3.1. Distributors
11.3.2. E Commerce
11.3.2.1. Company Websites
11.3.2.2. Online Marketplaces
12. Dried Blood Spot Collection Cards Market, by Sample Type
12.1. Introduction
12.2. Plasma Spots
12.3. Serum Spots
12.4. Whole Blood Spots
13. Americas Dried Blood Spot Collection Cards Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Dried Blood Spot Collection Cards Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Dried Blood Spot Collection Cards Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Danaher Corporation
16.3.2. PerkinElmer, Inc.
16.3.3. Ahlstrom-Munksjö Oyj
16.3.4. Bio-Rad Laboratories, Inc.
16.3.5. Roche Holding AG
16.3.6. Thermo Fisher Scientific Inc.
16.3.7. Agilent Technologies, Inc.
16.3.8. Becton, Dickinson and Company
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DRIED BLOOD SPOT COLLECTION CARDS MARKET MULTI-CURRENCY
FIGURE 2. DRIED BLOOD SPOT COLLECTION CARDS MARKET MULTI-LANGUAGE
FIGURE 3. DRIED BLOOD SPOT COLLECTION CARDS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DRIED BLOOD SPOT COLLECTION CARDS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DRIED BLOOD SPOT COLLECTION CARDS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. DRIED BLOOD SPOT COLLECTION CARDS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISEASE SURVEILLANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORENSIC TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CONGENITAL HYPOTHYROIDISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHENYLKETONURIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHARMACOKINETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY ANTIEPILEPTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FILTER PAPER CARDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POLYMER COATED CARDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COMPANY WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY ONLINE MARKETPLACES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PLASMA SPOTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SERUM SPOTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY WHOLE BLOOD SPOTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 62. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 63. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 66. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 67. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 68. CANADA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 69. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 71. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 72. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 76. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 115. GERMANY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. GERMANY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 117. GERMANY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 118. GERMANY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. GERMANY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. GERMANY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. GERMANY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 122. GERMANY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 123. GERMANY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. FRANCE DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 126. FRANCE DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 127. FRANCE DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 128. FRANCE DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. FRANCE DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. FRANCE DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 131. FRANCE DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 132. FRANCE DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 142. ITALY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. ITALY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 144. ITALY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 145. ITALY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. ITALY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. ITALY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. ITALY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 149. ITALY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 150. ITALY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 151. SPAIN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. SPAIN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 153. SPAIN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 154. SPAIN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 155. SPAIN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. SPAIN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. SPAIN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 158. SPAIN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 159. SPAIN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 178. SOUTH AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 187. DENMARK DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. DENMARK DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 189. DENMARK DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 190. DENMARK DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. DENMARK DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. DENMARK DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. DENMARK DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 194. DENMARK DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 195. DENMARK DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 205. QATAR DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. QATAR DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 207. QATAR DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 208. QATAR DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. QATAR DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. QATAR DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. QATAR DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 212. QATAR DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 213. QATAR DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 214. FINLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. FINLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 216. FINLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 217. FINLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. FINLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. FINLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. FINLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 221. FINLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 222. FINLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 223. SWEDEN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. SWEDEN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 241. EGYPT DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. EGYPT DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 243. EGYPT DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 244. EGYPT DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. EGYPT DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. EGYPT DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. EGYPT DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 248. EGYPT DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 249. EGYPT DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 250. TURKEY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 251. TURKEY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 252. TURKEY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 253. TURKEY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 254. TURKEY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. TURKEY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. TURKEY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 257. TURKEY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 258. TURKEY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 259. ISRAEL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 268. NORWAY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. NORWAY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 270. NORWAY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 271. NORWAY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. NORWAY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. NORWAY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. NORWAY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 275. NORWAY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 276. NORWAY DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 277. POLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. POLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 279. POLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 280. POLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. POLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. POLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. POLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 284. POLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 285. POLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 286. SWITZERLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. SWITZERLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY INDIRECT SALES, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY E COMMERCE, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 295. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET S

Companies Mentioned

The companies profiled in this Dried Blood Spot Collection Cards market report include:
  • Danaher Corporation
  • PerkinElmer, Inc.
  • Ahlstrom-Munksjö Oyj
  • Bio-Rad Laboratories, Inc.
  • Roche Holding AG
  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages191
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 406.04 Million
Forecasted Market Value ( USD ) by 2030 $ 533.13 Million
Compound Annual Growth Rate5.6%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Dried Blood Spot Collection Cards Market Size, Share & Trends Analysis Report by Application (Newborn Screening, Infectious Disease Testing, Forensics), Card Type (Whatman 903, Ahlstrom 226), End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Dried Blood Spot Collection Cards Market Size, Share & Trends Analysis Report by Application (Newborn Screening, Infectious Disease Testing, Forensics), Card Type (Whatman 903, Ahlstrom 226), End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Dried Blood Spot Collection Cards - Global Strategic Business Report - Product Image

Dried Blood Spot Collection Cards - Global Strategic Business Report

  • Report
  • 381 Pages
  • Global
From
2025 Global Forecast for Dried Blood Spot Collection Cards Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Dried Blood Spot Collection Cards Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
Dried Blood Spots. Applications and Techniques. Edition No. 1. Wiley Series on Pharmaceutical Science and Biotechnology: Practices, Applications and Methods - Product Image

Dried Blood Spots. Applications and Techniques. Edition No. 1. Wiley Series on Pharmaceutical Science and Biotechnology: Practices, Applications and Methods

  • Book
  • 376 Pages
Automatic Blood Coagulation Analysis Pipeline Market by Product, Technology, End User, Test Type - Global Forecast to 2030 - Product Image

Automatic Blood Coagulation Analysis Pipeline Market by Product, Technology, End User, Test Type - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From

About the Dried Blood Spot Market

The Dried Blood Spot (DBS) market is a subset of the coagulation and hemostasis testing market. DBS is a method of collecting and testing blood samples that involves collecting a small amount of blood on a filter paper card. This method is used to test for a variety of conditions, including hemophilia, thrombophilia, and other bleeding disorders. DBS is a cost-effective and convenient alternative to traditional venipuncture, as it requires less blood and can be collected in a variety of settings. The DBS market is expected to grow due to the increasing prevalence of bleeding disorders, the growing demand for point-of-care testing, and the increasing adoption of DBS technology. Additionally, the development of new technologies and the increasing availability of DBS kits are expected to drive the market growth. Some of the major companies in the DBS market include Siemens Healthineers, Roche Diagnostics, Abbott Laboratories, Sysmex Corporation, and Grifols. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.